| Code | CSB-MP3648HU |
| Abbreviation | Recombinant Human TFRC protein, partial (Active) |
| MSDS | |
| Size | $104 |
| Order now | |
| Image |
|
| Have Questions? | Leave a Message or Start an on-line Chat |
Transferrin receptor protein 1 mediates cellular iron uptake through endocytosis of iron-loaded transferrin, a process frequently dysregulated in rapidly proliferating cancer cells, making TFRC a target for therapeutic intervention and diagnostic imaging. This mammalian-expressed construct spanning residues 89–760 captures the extracellular ligand-binding domain and demonstrates quantified binding to both anti-TFRC recombinant antibody (EC50 3.305–8.220 ng/mL) and human transferrin (EC50 33.20–40.09 ng/mL) in functional ELISA, providing validated reagent performance for competitive inhibition assays, therapeutic antibody epitope mapping, and small-molecule inhibitor screening campaigns. The mammalian expression system supports native glycosylation and disulfide bond formation critical for conformational integrity in receptor-ligand interaction studies, including surface plasmon resonance and biolayer interferometry affinity characterization. With purity exceeding 95% by SDS-PAGE and endotoxin below 1.0 EU/μg, this protein aligns with standards expected in antibody screening workflows and serves as a positive control in binding assays targeting iron metabolism pathways in oncology research.
There are currently no reviews for this product.